Literature DB >> 8581948

Immunolocalization of a gonadotropin-releasing hormone receptor site in murine endometrium that mediates apoptosis.

W J Murdoch1.   

Abstract

Circumstantial evidence from a previous study indicated that antibodies generated against a synthetic N-terminal extracellular domain mouse pituitary gonadotropin-releasing hormone (GnRH) receptor peptide acted directly on the murine uterus affecting endometrial regression. Affinity-purified polyclonal sheep antibodies were used to assess tissue-specificity of antibody reactions in diestrous mice. Antibody binding was localized by immunofluorescence staining to anterior pituitary gland and endometrium. Ovary, brain, liver, kidneys, heart, lungs, spleen, gastrointestinal tract, adrenal glands, thymus, thyroid gland, muscle, and adipose were unreactive. Fragmented deoxyribonucleic acid, a marker of programmed cell death/apoptosis, was detected by digoxigenin labeling-immunoperoxidase in endometrial (but not pituitary) glands of animals injected with antipeptide antibodies or native ligand. It appears that luteal phase endometrium of mice expresses a GnRH receptor moiety that is coupled to a cell death (endonuclease) transduction pathway.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581948     DOI: 10.1007/bf00318886

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  16 in total

Review 1.  A biochemical hallmark of apoptosis: internucleosomal degradation of the genome.

Authors:  M M Compton
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  Monoclonal antibody-mediated tumor regression by induction of apoptosis.

Authors:  B C Trauth; C Klas; A M Peters; S Matzku; P Möller; W Falk; K M Debatin; P H Krammer
Journal:  Science       Date:  1989-07-21       Impact factor: 47.728

3.  The role of apoptosis in antibody-dependent cellular cytotoxicity.

Authors:  S J Curnow; M J Glennie; G T Stevenson
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

Review 4.  Ovarian follicle atresia: a hormonally controlled apoptotic process.

Authors:  A J Hsueh; H Billig; A Tsafriri
Journal:  Endocr Rev       Date:  1994-12       Impact factor: 19.871

Review 5.  Molecular function of the gonadotropin-releasing hormone receptor: insights from site-directed mutagenesis.

Authors:  J S Davidson; C A Flanagan; I I Becker; N Illing; S C Sealfon; R P Millar
Journal:  Mol Cell Endocrinol       Date:  1994-04       Impact factor: 4.102

6.  Programmed death of T cells in HIV-1 infection.

Authors:  L Meyaard; S A Otto; R R Jonker; M J Mijnster; R P Keet; F Miedema
Journal:  Science       Date:  1992-07-10       Impact factor: 47.728

7.  Immunization of mice against a synthetic N-terminal extracellular domain gonadotropin-releasing hormone receptor peptide: evidence for a direct uterine effect.

Authors:  A L Asirvatham; G A Johnson; E L Belden; E A Van Kirk; G E Moss; W J Murdoch
Journal:  Am J Reprod Immunol       Date:  1994-09       Impact factor: 3.886

8.  Induction of apoptotic or lytic death in an ovarian adenocarcinoma cell line by antibodies generated against a synthetic N-terminal extracellular domain gonadotropin-releasing hormone receptor peptide.

Authors:  R C Ackerman; G A Johnson; E A Van Kirk; A L Asirvatham; W J Murdoch
Journal:  Cancer Lett       Date:  1994-06-30       Impact factor: 8.679

9.  Gonadotropin-releasing hormone specific binding sites in uterine leiomyomata.

Authors:  A Wiznitzer; M Marbach; E Hazum; V Insler; Y Sharoni; J Levy
Journal:  Biochem Biophys Res Commun       Date:  1988-05-16       Impact factor: 3.575

Review 10.  The Fas death factor.

Authors:  S Nagata; P Golstein
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

View more
  6 in total

1.  GnRH antagonists may affect endometrial receptivity.

Authors:  Beth W Rackow; Harvey J Kliman; Hugh S Taylor
Journal:  Fertil Steril       Date:  2008-04-14       Impact factor: 7.329

Review 2.  Effects of gonadotrophin-releasing hormone outside the hypothalamic-pituitary-reproductive axis.

Authors:  D C Skinner; A J Albertson; A Navratil; A Smith; M Mignot; H Talbott; N Scanlan-Blake
Journal:  J Neuroendocrinol       Date:  2009-03       Impact factor: 3.627

3.  Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes.

Authors:  Laura Detti; Dana R Ambler; Frank D Yelian; Michael L Kruger; Michael P Diamond; Elizabeth E Puscheck
Journal:  J Assist Reprod Genet       Date:  2008-05-07       Impact factor: 3.412

4.  Immunochemical characteristics of a novel cell death receptor and a decoy receptor on granulosa cells of porcine ovarian follicles.

Authors:  N Manabe; A Myoumoto; C Tajima; M Fukumoto; M Nakayama; K Uchio; M Yamaguchi; H Miyamoto
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

5.  Antibodies against gonadotropin-releasing hormone (GnRH) in patients with diabetes mellitus is associated with lower body weight and autonomic neuropathy.

Authors:  Kerstin Berntorp; Anders Frid; Ragnar Alm; Gunilla Nordin Fredrikson; Klas Sjöberg; Bodil Ohlsson
Journal:  BMC Res Notes       Date:  2013-08-17

6.  GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial.

Authors:  Francesco M Fusi; Claudio M Brigante; Laura Zanga; Mario Mignini Renzini; Chiara Bosisio; Rubens Fadini
Journal:  Reprod Biol Endocrinol       Date:  2019-11-29       Impact factor: 5.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.